Israel Innovation Authority

The Israel Innovation Authority, established in 1965 as the Office of the Chief Scientist within the Ministry of Industry and Trade, is dedicated to fostering research and development in government research institutes. Its primary objective is to enhance industrial development and promote the export of high-tech products. The authority plays a crucial role in mitigating financial risks associated with innovation projects by providing funding support to initiatives selected and managed by private companies. Through these efforts, it aims to stimulate growth in the high-tech sector and strengthen Israel's position as a leader in innovation.

Dror Bin

CEO

177 past transactions

RepAir

Grant in 2025
RepAir is a company focused on developing innovative technology to facilitate carbon removal from the atmosphere, aiming to contribute to a carbon-negative future. The company has created an electrochemical device that efficiently captures carbon dioxide by utilizing electricity. This device streams atmospheric air through a unique membrane that selectively separates carbon dioxide, releasing clean air back into the environment. RepAir's technology is designed for large-scale deployment, emphasizing environmental sustainability through its fully electric operation, which requires minimal energy and generates no hazardous materials or waste. By promoting renewable energy sources and reducing energy costs, RepAir positions itself as a leader in the transition towards more sustainable carbon management solutions.

Brain.space

Grant in 2025
Brain.space is a data company focused on brain mapping, aiming to support researchers, medical professionals, and software developers in interpreting and analyzing brain activity. The company offers a comprehensive and affordable technology stack that includes noninvasive brain activity mapping and monitoring, along with validated big data interpretation and insights. This platform enables users to develop innovative products and services that leverage brain activity data, facilitating advancements in various fields related to neuroscience and mental health.

QuamCore

Seed Round in 2025
We're Building the Next Big Thing

nT-Tao Compact Fusion Power

Grant in 2025
nT-Tao is building a compact fusion reactor that will generate 10-20 MW of electricity. The reactor is highly scalable and will be about the size of a shipping container, ensuring clean fusion energy wherever needed. The reactor’s scalability and affordability will make it suitable for various power needs, ranging from industrial and manufacturing facilities to small towns and off-grid locations. This scalability coupled with the ability for rapid deployment, positions nT-Tao’s reactor as a versatile and adaptable fusion energy solution. nT-Tao’s unique solution relies on a proprietary plasma heating method which is expected to reach 1000 times higher density than other fusion reactors, thereby making its fusion reaction 1 million times more effective. nT-Tao’s ability for quick development iterations and its groundbreaking approach, dramatically reduces the size, cost, and complexity of fusion energy reactors. Co-founded by Oded Gour-Lavie, Doron Weinfeld, and Boaz Weinfeld, nT-Tao’s mission is to develop a unique nuclear fusion technology that will enable the world to transition towards a cleaner, decarbonized, sustainable, and advanced future.

IBI-Ag

Grant in 2025
IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides designed to provide environmentally friendly pest management solutions for agriculture. The company focuses on creating natural single-domain antibody insecticides that enhance crop production while ensuring safety for farm workers, consumers, and the environment. IBI-Ag employs advanced technology to produce efficient and selective bio-insect control solutions, which are cost-effective due to their suitability for fermentation. This approach allows farmers to cultivate their crops at lower costs while benefiting from customized biological pest control options that are based on comprehensive testing and research. Through its commitment to sustainability and innovation, IBI-Ag aims to support farmers worldwide in achieving safe and productive agricultural practices.

Lowental Hybrid

Seed Round in 2025
Lowental Hybrid specializes in developing hybrid propulsion systems for Unmanned Aerial Vehicles (UAVs). Their technology combines fuel-based propulsion with electric power, allowing UAVs to operate for longer durations while maintaining the low noise levels of electric systems. The company's advanced parallel hybrid solution, comprising an electric motor and an internal combustion engine, enables vertical take-off using electricity and extends flight times up to fivefold, making it ideal for extended and demanding missions.

Promise Bio

Grant in 2024
Promise Bio is a biotechnology company specializing in precision medicine for autoimmune diseases. It leverages epiproteomic analysis, a cutting-edge technique that examines protein modifications, using a cloud-based AI platform to interpret standard mass-spectrometry data. This innovative approach aims to uncover disease mechanisms and facilitate personalized treatment plans, ultimately improving patient care and affordability.

MICA

Grant in 2024
MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

i-EcoGuard

Seed Round in 2024
i-EcoGuard specializes in sustainable agriculture, utilizing advanced nanoparticle technology to enhance greenhouse efficiency. The company's core product is an innovative, self-adapting polymer that optimizes greenhouse conditions, promoting plant health, improving crop quality, and boosting energy efficiency.

Airobotics

Grant in 2024
Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

Eretz Angels

Grant in 2024
Eretz Angels supports technology startups in Israel's outskirts at the start of their journey.

Lidwave

Grant in 2024
Lidwave is a developer of advanced 3D sensing solutions aimed at transforming industries reliant on LiDAR technology. By introducing a novel three-dimensional sensing architecture, the company addresses significant limitations in traditional LiDAR and radar systems, particularly concerning bandwidth constraints. Its innovative Finite Coherence Ranging (FCR) technology delivers enhanced four-dimensional sensing capabilities, enabling precise Doppler and depth information. This breakthrough allows businesses to enhance automation across various sectors, including autonomous vehicles, industrial robotics, and smart cities, ultimately facilitating smarter and safer decision-making. Lidwave's approach not only resolves the challenges associated with existing sensing methods but also positions it as a leader in disruptive sensing technology.

Lavie Bio

Grant in 2024
Lavie Bio is a biotechnology company focused on developing microbial and biochemistry-based products aimed at enhancing agricultural practices. The company specializes in bio-stimulants and bio-pesticides that improve the quality and health attributes of crops. Its innovative offerings include bacterial compositions that can be sprayed on plants, applied as seed coatings, or integrated into soil, thereby enhancing plant features and overall yield. By leveraging natural biological sources, Lavie Bio provides ag-biological technology to businesses, facilitating sustainable agricultural solutions.

Pickommerce AI Robotics

Seed Round in 2024
Pickommerce is revolutionizing e-commerce logistics with its autonomous pick-and-pack robotic system, PickoBot. This innovative solution addresses labor constraints in the growing e-commerce sector by streamlining the picking and packing process. PickoBot's advanced computer vision system, powered by machine learning, allows it to handle a vast array of items with various grippers and packing algorithms. This adaptable technology seamlessly integrates into both automated and conventional warehouses, minimizing disruption while boosting efficiency and productivity. Pickommerce's patented adhesive picking methods and AI-driven decision-making algorithms ensure optimal grasp configuration and package box optimization.

SolidT

Grant in 2024
SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

TruLeaf Medical

Grant in 2024
TruLeaf Medical is a developer of user-friendly Transcatheter Mitral Valve Replacement (TMVR) solution.

IR-MED

Grant in 2024
IR-MED LTD. is a medical device company based in Rosh Pinna, Israel, specializing in infrared light-based diagnostic systems. Founded in 2012, the company leverages advanced technologies, including big data and machine learning, to create innovative diagnostic modalities. IR-MED develops continuous and real-time monitoring devices capable of detecting and measuring various substances and pharmaceuticals in the blood. Additionally, their systems can assess fluid concentrations on surfaces and behind thin tissues, facilitating the identification and characterization of medical lesions and pathological processes in humans.

Ocon Healthcare

Grant in 2024
OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

Eight Two Hundred Angels

Grant in 2024
Eight Two Hundred Angels is an investment firm, They assist in promoting the companies in which they invest, attract investors, and qualify investors interested in investing in innovative technologies and high-risk investments.

TEClub VC

Grant in 2024
TEClub VC is an investment firm for mega angels that invests in breakthrough technologies at early stages through a smart and selective investment platform. They focus on creating unicorn companies and venture creation models.

Nugen Clean Energy

Grant in 2024
Nugen Clean Energy specializes in off-grid electric vehicle (EV) charging systems. Their innovative technology uses a solid-state hydrogen compound to safely generate and utilize hydrogen on-site and on-demand, ensuring a reliable and sustainable power source even in remote locations. This enhances grid capacity and provides uninterrupted charging, making EV charging infrastructure more scalable and dependable.

Qualifire

Pre Seed Round in 2024
Qualifire is a real-time safety and quality control platform for LLM-based applications, enabling enterprises to deploy reliable, compliant, and trustworthy AI solutions. Qualifire intercepts and blocks inaccuracies, hallucinations, and policy violations in real time, safeguarding brand integrity and regulatory compliance. Qualifire supports the entire AI lifecycle from training and experimentation to deployment and oversight. Qualifire integrates seamlessly into any workflow, ensuring that AI outputs consistently align with organizational standards and strategic objectives. It empowers teams to confidently deploy AI that adheres to business and regulatory requirements, accelerating time-to-market while protecting against the risks of AI unpredictability.

AccuLine

Grant in 2024
AccuLine is a digital healthcare company dedicated to preventing heart attacks and saving lives through early detection of coronary artery disease (CAD). The company has developed CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. This innovative platform delivers swift and cost-effective assessments, allowing healthcare providers to identify CAD more effectively and efficiently. By replacing outdated and labor-intensive methods, AccuLine aims to enhance patient outcomes and revolutionize the way heart disease is diagnosed and managed.

Soltell Systems

Grant in 2024
Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

Sequentify

Grant in 2024
Sequentify is a biotechnology company that specializes in advanced DNA sequencing technologies, integrating synthetic biology with artificial intelligence software. The company focuses on providing innovative library-preparation methods for targeted DNA sequencing applications, including cancer diagnostics, carrier screening, and COVID-19 surveillance. By enabling rapid and cost-effective genomic diagnostics, Sequentify aims to support researchers and healthcare professionals in conducting population-wide genomic studies and therapeutic interventions.

FireDome

Grant in 2024
FireDome's revolutionary wildfire defense system takes a two-tiered strategy. First, a mechanical launcher quickly deploys a protective barrier to impede the direct route of advancing wildfires. Second, the system actively detects and promptly extinguishes spot fires created by airborne embers that bypass the primary barrier.

Charging Robotics

Grant in 2023
Charging Robotics engages in wireless charging solutions.

NurExone Biologic

Grant in 2023
NurExone Biologic is developing a biological exosome based technology drug platform to treat damage in the Central Nerve System.

Airobotics

Grant in 2023
Airobotics is a manufacturer of autonomous unmanned aerial drones that offers a comprehensive, fully automated solution for collecting aerial data and generating insights. The company serves various sectors, including government, industrial, and commercial industries. Airobotics specializes in automated data capture and analysis, providing services such as real-time video, disaster and scene assessment, compliance audits, land investigations, inspections, surveillance, progress monitoring, and survey services. By leveraging advanced drone technology, Airobotics enables organizations to efficiently gather critical data and make informed decisions.

CODA

Grant in 2023
CODA is a cloud-based AI platform that translates spoken language into sign language and provides the deaf community with easier access to video content in their preferred language.

Maris Tech

Grant in 2023
Maris-Tech is a global leader in video and AI-based edge computing technology, pioneering intelligent video transmission solutions that conquer complex encoding-decoding challenges. Our miniature, lightweight, and low-power products deliver high-performance capabilities including raw data processing, seamless transfer, advanced image processing, and AI-driven analytics. Founded by Israel technology sector veterans, Maris-Tech serves leading manufacturers worldwide in defense, aerospace, Intelligence gathering, homeland security (HLS) and communication industries worldwide. We’re pushing the boundaries of video transmission and edge computing, driving innovation in mission-critical applications across commercial and defense sectors.

Microbot Medical

Grant in 2023
Microbot Medical is a medical device company based in Hingham, Massachusetts, founded in 2010. It specializes in developing micro-robotic technologies for minimally invasive surgery. The company's key products include the Self Cleaning Shunt (SCS) for treating hydrocephalus and normal pressure hydrocephalus, TipCAT, a self-propelling endoscope initially designed for colonoscopy procedures, and Liberty, a combination of guidewire and microcatheter technologies for endoluminal surgery. Microbot Medical aims to enhance surgical outcomes by providing less invasive and more precise solutions, with 37 issued/allowed patents and 15 patent applications pending worldwide.

Pashoot Robotics

Grant in 2023
Pashoot Robotics specializes in contextual robotics tailored for the manufacturing sector. The company develops automation software that facilitates the flexible deployment of robotic arms, allowing them to perform tasks with human-like learning and adaptability. This innovative approach enables robots to not only execute pre-programmed functions but also to understand and adjust to their environments. By democratizing robotic automation, Pashoot Robotics empowers manufacturers to enhance productivity and competitiveness in their operations, making it easier for them to adopt advanced robotic solutions in their production lines.

SolidT

Grant in 2023
SolidT is at the forefront of innovation, pioneering a cutting-edge decentralized temperature control system based on solid-state technology. This revolutionary system empowers precise regulation of temperature for various components, such as batteries, battery cells, modules, high-frequency processors, displays, interiors, and more – all achieved without the need for traditional compressors and their associated systems. SolidT's groundbreaking technology promises to streamline automotive temperature control systems by simplifying complexity, shedding excess weight, and enhancing reliability. This innovation not only elevates efficiency and precision but also significantly slashes manufacturing costs and operational expenses. SolidT's disruptive system finds applications across diverse industries, including automotive, electronics, and high-energy devices, making it a game-changer for temperature management solutions.

EMRIS Pharma

Pre Seed Round in 2023
EMRIS Pharma takes care of the life and treatment compliance for cancer patients.

BloomX

Seed Round in 2023
BloomX is an AI pollination solution for crops in which pollination is a limiting factor for their yield. The company allows growers to increase their revenue by enlarging yields in existing crops and improving fruit quality. BloomX's vision is to provide an AI-based pollination solution that addresses each crop’s pollination needs by mimicking the natural pollination process and enhancing it using technology. Bumblebee was founded in 2019 and is headquartered in Tel Aviv, Israel.

MICA

Seed Round in 2023
MICA is a medical technology company focused on improving breast cancer diagnosis through artificial intelligence. It has developed a system that aids radiologists in the analysis and comparison of mammography images. By offering a range of products designed for mammogram analysis, image comparison, and medical records management, MICA aims to enhance the accuracy of breast cancer detection. The company's tools enable medical professionals to facilitate early diagnosis and treatment, ultimately contributing to a reduction in breast cancer incidence.

UB Therapeutics

Pre Seed Round in 2023
UB Therapeutics is a biotechnology company developing a novel therapy for the treatment of multiple myeloma.

Atiko Labs

Pre Seed Round in 2023
Atiko Labs specializes in creating innovative robotic solutions to address various challenges in agriculture, focusing on farming autonomy. The company designs and develops smart, custom-made robots that function like farmers, aiming to enhance efficiency and productivity in the agricultural sector. Additionally, Atiko Labs has developed a portable optical sensor capable of detecting materials or contaminants in production line samples. This technology provides rapid, high-resolution detection with accurate results delivered within seconds. The data collected is securely stored and analyzed in the cloud, allowing clients to identify target molecules on-site, thereby streamlining quality control processes in their operations.

NINA Medical

Seed Round in 2023
NINA Medical is a developer of innovative solutions for non-invasive surgery, focusing on enhancing patient outcomes by reducing bleeding, postoperative infections, pain, and overall trauma. The company specializes in a diagnostic-therapeutic system aimed at treating Benign Prostatic Hyperplasia (BPH) in office settings. NINA Medical's unique approach utilizes core technology that allows practitioners to visualize the high-intensity focused ultrasound (HIFU) beam in real-time, offering distinct advantages over traditional minimally invasive techniques. By advancing non-invasive treatment options, NINA Medical is expanding the potential of next-generation medicine.

Oversight

Grant in 2022
Oversight is a company that develops a 3D collaborative workspace platform aimed at enhancing decision-making for first responders. Its innovative platform integrates advanced artificial intelligence simulations and real-time data management from various devices, including drones, body cameras, and smartphones. This functionality allows emergency response teams to achieve comprehensive situational awareness, thereby improving mission planning and operational efficiency. By fusing diverse data sources into a single interactive environment, Oversight empowers clients to make informed decisions during critical situations, ultimately supporting their efforts in emergency response.

Dio Tree

Seed Round in 2022
DioTree is a biotechnology company specializing in the development of innovative treatments for high-grade serous ovarian cancer (HGSOC). The company's core focus is to inhibit the enzyme DIO3, which plays a significant role in driving ovarian cancer progression, by utilizing a novel mechanism of action and small molecule technology. DioTree aims to advance cancer treatment frontiers, enabling medical professionals to provide more effective care and positively impacting the lives of those affected by this disease.

Enzymit

Non Equity Assistance in 2022
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Navina

Grant in 2022
Navina is a technology company that specializes in developing an AI-driven platform aimed at transforming patient data into clear and actionable patient portraits. This innovative platform addresses the challenges posed by disorganized patient information, allowing physicians to quickly assess complex cases and make informed diagnoses. By utilizing artificial intelligence and machine learning, Navina's technology organizes critical data to highlight essential clinical insights, enabling healthcare providers to enhance patient care while increasing efficiency at the point of care. The platform not only aims to improve patient outcomes but also contributes to better financial performance for healthcare providers and payers. Additionally, Navina collaborates with the American Academy of Family Physicians Innovation Lab to further its mission in the healthcare sector.

BioBetter

Series A in 2022
BioBetter is a foodtech company based in Israel, established in 2015. It specializes in developing plant-based platforms for the production of complex growth factors essential for cultivated meat. The company leverages agri-tech innovations to simplify the manufacturing and purification processes of proteins, particularly focusing on the use of transgenic plants as bioreactors. By co-expressing therapeutic proteins with enzymes that eliminate antigenic sugars, BioBetter enhances the efficiency of protein expression, enabling biotech professionals to significantly reduce production costs.

VREE LABS

Pre Seed Round in 2022
VRee AI develops state of the art 3D technologies based on AI methods such as NeRF and deep learning, to generate 3D models for AR/VR environments. We basically help turning 2D images into 3D models in the blink of an AI.

SuperMeat

Grant in 2022
SuperMeat is an Israeli bio-tech and food-tech company based in Tel Aviv, founded in 2015. It specializes in producing cultured meat from chicken cells in a sterile and controlled environment, eliminating the need for antibiotics and reducing the risk of contamination from pathogens such as salmonella. The company aims to revolutionize the meat industry by providing a sustainable alternative to traditional poultry farming, significantly decreasing resource requirements—99% less land and 90% less water—while offering a product that maintains a rich flavor and aroma. SuperMeat's innovative approach aspires to enhance nutritional security and reduce carbon emissions, contributing to a healthier future for both humans and animals.

VALFIX

Grant in 2022
VALFIX Medical, established in 2016 and based in Tel Aviv, Israel, specializes in the design and development of transcatheter solutions for Mitral and Tricuspid valve repair and replacement. The company's innovative, minimally-invasive approach combines repair and replacement treatments, providing a viable alternative to open-heart surgery. Utilizing its proprietary multi-wire technology, VALFIX aims to alleviate heart failure symptoms and treat various heart-related conditions by addressing mitral regurgitation.

Brevel

Grant in 2022
Brevel is a company that specializes in innovative cultivation technology for microalgae, aimed at producing sustainable and high-quality products for various emerging markets. Utilizing advanced indoor systems that are sterile and fully automated, Brevel's method employs high-intensity internal illumination, resulting in significant cost reductions of over 90% and yield increases of up to 200 times compared to traditional methods. This breakthrough technology positions Brevel to capitalize on the growing demand for microalgae-derived products in sectors such as food, materials, chemicals, pharmaceuticals, and energy, providing an alternative protein source suitable for mass production.

Enlivex Therapeutics

Grant in 2022
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Olive Diagnostics

Seed Round in 2022
Olive Diagnostics is a company that has developed an innovative passive urine analysis sensor designed to enhance early disease detection and chronic disease management. This sensor, which can be easily mounted to any toilet, utilizes spectroscopy combined with artificial intelligence-based analytics to monitor the urine stream. By continuously collecting and analyzing health data, the device provides users with real-time health alerts that promote awareness of their bodily functions. The technology not only supports individual health management but also offers valuable insights for pharmaceutical and contract research organizations to track drug compliance and usage. With its focus on proactive health monitoring, Olive Diagnostics aims to make urine lab services accessible even in nonindustrial nations, thereby transforming personal health care through advanced, continuous biomarker tracking.

Gemma

Seed Round in 2022
Gemma is focused on revolutionizing the makeup experience for women by developing an automatic makeup application machine. This innovative device simplifies the process of applying makeup, enabling users to achieve various looks in under two minutes using automated airbrush technology and real-time color mixing. Gemma's patented technology empowers women to select their desired makeup look, essentially providing the benefits of a professional makeup artist in the comfort of their own homes. By streamlining makeup application, Gemma aims to enhance the confidence and convenience for busy individuals seeking a quick and effective beauty solution.

Cybord

Seed Round in 2022
Cybord is a technology company focused on preventing counterfeit, defective, and malicious electronic components from entering the manufacturing process. The company employs deep learning algorithms and artificial intelligence to assess each component before its placement, utilizing a comprehensive global database of electronic parts. By integrating its system with electronic product manufacturing equipment, Cybord enhances component traceability through material inspection, documentation, and visual imagery, which collectively establish the provenance of materials. This approach not only helps original equipment manufacturers (OEMs), electronics manufacturing services (EMS), and distributors ensure the quality and security of their products but also addresses the significant issue of counterfeit components, which account for a notable percentage of return merchandise authorizations. Cybord's innovative solutions ultimately aim to improve product quality and reduce risks associated with hardware-cyber threats.

AccuLine

Grant in 2022
AccuLine is a digital healthcare company dedicated to preventing heart attacks and saving lives through early detection of coronary artery disease (CAD). The company has developed CORA, a non-invasive examination technology that provides a smart, accurate, and user-friendly alternative to traditional stress tests. This innovative platform delivers swift and cost-effective assessments, allowing healthcare providers to identify CAD more effectively and efficiently. By replacing outdated and labor-intensive methods, AccuLine aims to enhance patient outcomes and revolutionize the way heart disease is diagnosed and managed.

DermaDetect

Seed Round in 2022
DermaDetect is a developer of an AI-driven digital dermatology platform that focuses on the analysis and management of skin disorders, including non-pigmented lesions and acute diseases. The platform allows patients to conduct self-assessments of their skin, hair, and nails, facilitating remote diagnosis and treatment of various skin conditions. By automatically detecting skin issues, DermaDetect not only recommends appropriate treatments but also connects patients with nearby physicians, ensuring they receive timely care from the comfort of their homes. This innovative approach empowers individuals to manage their dermatological health effectively and conveniently.

DermaDetect

Seed Round in 2022
DermaDetect is a developer of an AI-driven digital dermatology platform that focuses on the analysis and management of skin disorders, including non-pigmented lesions and acute diseases. The platform allows patients to conduct self-assessments of their skin, hair, and nails, facilitating remote diagnosis and treatment of various skin conditions. By automatically detecting skin issues, DermaDetect not only recommends appropriate treatments but also connects patients with nearby physicians, ensuring they receive timely care from the comfort of their homes. This innovative approach empowers individuals to manage their dermatological health effectively and conveniently.

Alumor

Grant in 2021
Alumor develops solar-powered water purification technology devices based on ultraviolet LED light which can purify any type of surface water, including lakes, rivers, lagoons, and pools.

MagniLearn

Seed Round in 2021
MagniLearn is an AI-focused startup that specializes in delivering personalized educational experiences for students. The company has developed an innovative platform that harnesses artificial intelligence and natural language processing to create customized lessons tailored to individual learning progress. By autonomously generating lessons and providing real-time feedback on errors, MagniLearn fosters an efficient learning environment that addresses students' specific needs. This approach enables students to engage more effectively with language lessons, facilitating their journey toward proficiency through targeted instruction and constructive guidance.

YieldX Solutions

Pre Seed Round in 2021
Precision Ag-Biosecurity Data Platform For Livestock Farming.

BeeHero

Grant in 2021
BeeHero is a company that specializes in beehive technology aimed at enhancing crop yields through efficient pollination. Founded in 2017 by Itai Kanot, Omer Davidi, and Yuval Regev, the company leverages artificial intelligence and machine learning, utilizing low-cost sensors to gather data from within beehives. This innovative approach helps stimulate optimal bee productivity during critical pollination periods, thereby assisting farmers in safeguarding their beehives against colony collapse and improving overall pollination effectiveness. With operations based in Tel Aviv and Silicon Valley, BeeHero employs a team of 50 individuals, with a significant portion dedicated to research and development in its Israeli center.

Kipp Authorize More

Grant in 2021
Kipp enables card issuers and merchants to approve more transactions, leading to higher customer satisfaction and greater revenue. Kipp's platform serves and supports issuer banks in optimizing their cards' business, leveraging their relationships with merchants, their willingness to share data and participate in the cost of risk.

Silib

Venture Round in 2021
Silib is a battery manufacturing company that specializes in developing advanced pure silicon anodes for lithium-ion batteries. By utilizing a novel, low-cost manufacturing process that does not require catalysts, precious metals, or binders, Silib's anodes can enhance battery capacity by over 40%, achieving energy densities exceeding 1000Wh/L. The company's unique nanostructured silicon technology allows for high mass loading, which enables a reduction in battery size while maintaining the same energy content or improving capacity. Silib's anodes are designed to be compatible with any cell format, serving as a drop-in replacement for traditional graphite-based anodes, thereby providing significant advantages in battery performance.

Ripe Guard

Seed Round in 2021
Ripe Guard is a technology company focused on reducing waste in the fruit and vegetable industry through its innovative platform for predicting shelf life. The company addresses the significant issue of depreciation and waste, which affects up to 45% of the produce grown, resulting in substantial economic losses and environmental impact. By providing accurate predictions of when produce will ripen and spoil, Ripe Guard enables food producers to optimize the shelf life of their products. This technology aims to create efficiencies throughout the supply chain, ultimately saving resources, increasing food availability, and promoting sustainability within the global fruit and vegetable markets.

Tiktalk To Me

Series A in 2021
Tiktalk To Me owns and operates a digital health company intended to offer a platform for speech therapy. Its platform functions as a virtual speech therapist, guiding patients through proven and widely accepted training protocols using online games supervised by the patient's personal speech therapist and combines gaming with speech- and voice-recognition technology, enabling speech-language pathologists to shorten the treatment cycle and save substantial time and money for the patients.

Growee

Seed Round in 2021
Growee is a company focused on enhancing home gardening and urban farming through innovative hydroponic technology. Their electronic hydroponic device allows users to effortlessly monitor and control their systems via smartphones, making the cultivation of fresh, healthy produce accessible to all experience levels. The device automatically balances pH levels and fertilizers, while also monitoring essential environmental factors such as temperature, humidity, and nutrient levels. By promoting resource efficiency, Growee helps users reduce nutrition costs significantly, conserve water, and lower CO2 emissions. The system is designed for easy installation and can be integrated into various spaces, including backyards and urban areas. Additionally, Growee offers advanced analytics and insights to optimize crop rotation and maximize yields, thus revolutionizing small-scale farming. Through real-time sensing and precise feeding algorithms, Growee is committed to fostering a more sustainable approach to growing local produce.

Mush Foods

Pre Seed Round in 2021
Mush Foods, based in New York, specializes in cultivating edible mushroom mycelium as an innovative food source. Their debut product line, 50CUT, is a unique blend that integrates seamlessly with real animal meat, offering consumers a more sustainable and nutritious option. By utilizing fermentation and artificial intelligence, Mush Foods efficiently produces its fungi-based ingredients, aiming to reduce the carbon footprint by half while enhancing taste and affordability.

IBI-Ag

Grant in 2021
IBI-Ag is a biotechnology company dedicated to developing innovative bioinsecticides designed to provide environmentally friendly pest management solutions for agriculture. The company focuses on creating natural single-domain antibody insecticides that enhance crop production while ensuring safety for farm workers, consumers, and the environment. IBI-Ag employs advanced technology to produce efficient and selective bio-insect control solutions, which are cost-effective due to their suitability for fermentation. This approach allows farmers to cultivate their crops at lower costs while benefiting from customized biological pest control options that are based on comprehensive testing and research. Through its commitment to sustainability and innovation, IBI-Ag aims to support farmers worldwide in achieving safe and productive agricultural practices.

ViAqua Therapeutics

Grant in 2021
ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

Ark Surgical

Seed Round in 2021
Ark Surgical is a commercial-stage medical device start-up that specializes in laparoscopic surgery. The company is dedicated to developing and commercializing innovative solutions that enhance safety during minimally invasive procedures. Its flagship product, LapBox, is a user-friendly containment system designed to prevent the dispersion of cancerous tissue during surgeries, particularly in the context of women's health. This device has received FDA clearance, and a second iteration is in development. By facilitating the contained removal of large internal organs through laparoscopic keyhole incisions, Ark Surgical's products significantly reduce the risks associated with traditional tissue morcellation, allowing surgeons to perform safer and more effective minimally invasive surgeries.

CorrActions

Seed Round in 2021
CorrActions is a developer of a software-based digital technology platform that focuses on enhancing human-machine interaction. The platform is designed to detect, decode, and transform human brain signals in real-time, aiming to prevent human errors. By leveraging artificial intelligence, CorrActions enables machines to learn human behavior more effectively, thereby improving overall efficiency in various sectors. Its applications span across aviation, automotive, medical, and technology industries, where it seeks to revolutionize the interaction between humans and machines through a brain-computer interface. This innovative approach enhances human learning efficiency and facilitates smarter machine operation in complex environments.

Enlivex Therapeutics

Grant in 2021
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Skip Therapeutics

Seed Round in 2021
Skip Therapeutics is a biotechnology company focused on developing precision, RNA-based treatments for rare genetic diseases. With millions of people affected by various rare genetic disorders, the company aims to overcome challenges in treatment discovery caused by limited patient populations and specific mutations. By leveraging recent advancements in RNA therapeutics, Skip Therapeutics utilizes splice-modulating antisense oligonucleotides to analyze mutation data at scale. This approach enables the identification of treatable patient cohorts, optimizes target selection, and recognizes effective molecular strategies to restore protein function. Through computational techniques, the company seeks to match RNA-based therapeutic options to the vast landscape of known disease-causing mutations, thereby enhancing the potential for tailored medical interventions.

AQUALITAS

Pre Seed Round in 2021
Aqualitas specializes in developing a modular water quality monitoring system that operates continuously and requires minimal maintenance. Their platform allows customers to select specific physicochemical parameters for monitoring, while the system utilizes self-diagnosis and automated processes to streamline operations. By leveraging Internet of Things (IoT) technology, Aqualitas collects real-time water quality data, which is analyzed and transformed into actionable insights delivered to users through a software-as-a-service (SaaS) platform. This approach eliminates the need for an initial investment in equipment, enabling customers to expand their monitoring capabilities as their needs grow. Aqualitas's use of artificial intelligence and machine learning further enhances the system by ensuring sensor operational stability and automatic calibration, ultimately resulting in lower costs and improved efficiency for industries reliant on accurate water quality data.

Spectalix

Grant in 2021
Spectalix is a technology company that provides a unique white-label user-generated content (UGC) platform designed to help brands regain user engagement on their own digital assets, such as apps and websites. By leveraging advanced AI video technology, including proprietary background replacement and image segmentation techniques, Spectalix allows users to interact with brand content in innovative ways. Users can create personalized clips, featuring themselves with their favorite sports teams, musicians, or TV shows, utilizing their smartphones. These personalized clips can then be shared across various social media platforms, allowing users to act as micro-influencers. Additionally, Spectalix prioritizes brand safety through an automated moderation mechanism that ensures user content aligns with brand standards, unlike traditional social media environments.

ZygoFix

Seed Round in 2021
ZygoFix is a medical device company specializing in spine technology. It has developed an innovative three-dimensional-printed implant designed to lock the facet joint of the lumbar spine. This device leverages the anatomy of the spine to provide stability, eliminating the need for traditional external screw-based bridges and reducing the reliance on pedicle screws. By doing so, ZygoFix aims to minimize the risks associated with improper screw placement, thereby enhancing safety in spinal surgeries. The company's focus on advancing spinal stability reflects its commitment to improving patient outcomes in the medical field.

Anicca

Grant in 2021
Anicca is a mental health company focused on developing innovative technology for managing stress and emotional well-being. The company has created a wearable device that features a smart respiration sensor, which measures users' breathing patterns. This device also incorporates a tactile stimulation mechanism that delivers haptic feedback through pleasant vibrations synchronized with the user's breathing. By promoting better focus, improved sleep, and reduced anxiety, Anicca's product aims to provide users with an effective tool for on-the-go emotion and stress management.

Flytrex

Grant in 2021
Flytrex is the largest drone-based food delivery service in the United States, specializing in ultrafast delivery within suburban areas. Operating in North Carolina and Texas, the company delivers food seven days a week and has successfully completed over 120,000 orders for partners including Little Caesars, Papa John's, and El Pollo Loco. Flytrex's innovative drone technology utilizes automated drones controlled via a cloud-based dashboard, optimizing delivery efficiency and significantly reducing costs. This service has lowered suburban delivery expenses from $10 to $1 per package and cut delivery times from 20 minutes to under five. With a 45% monthly retention rate after two years and a high household penetration of 70% within range, Flytrex has garnered strong customer loyalty, reflected in a Net Promoter Score of 75.

FertilAI

Grant in 2021
FertilAI is a healthcare company focused on enhancing fertility treatment success rates through innovative technologies. Based in Israel, the company leverages advanced AI algorithms to automate and optimize clinical decision-making for physicians during fertility treatments. Its flagship platform, Fertilane, enables seamless communication among clinics, doctors, and patients through specialized doctor/patient applications and administrative web applications designed for fertility workflows. Founded by a team of technology experts and leading reproductive endocrinologists, FertilAI aims to elevate the overall patient experience in fertility care while supporting clinics in their operational scalability.

ThermoTerra

Seed Round in 2020
ThermoTerra captures a new source of renewable energy, powered by natural fluctuations in humidity - Humidity Power - to heat and cool build.

Enzymit

Non Equity Assistance in 2020
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Phytolon

Funding Round in 2020
Phytolon Ltd is a company based in Misgav, Israel, specializing in the development of natural food colorants. Founded in 2000, Phytolon utilizes a novel fermentation technology that employs baker's yeast cells as biofactories to produce high-quality, plant-based food colors. This innovative approach offers a healthy alternative to synthetic food dyes, providing food manufacturers with safe, cost-effective, and stable all-natural color solutions. The company's mission is to leverage scientific advancements to promote human health and environmental sustainability in the food industry.

High Lander

Seed Round in 2020
High Lander is a technology company that specializes in converting off-the-shelf drones into pilot-less, autonomous systems through its innovative software solution. Its Mission Control platform enables users to manage a fleet of drones, enhancing operational efficiency in various applications such as first response, aerial security, and precision agriculture. Additionally, High Lander develops drone flight plan technology that addresses the challenge of short battery life, allowing for the establishment of commercial drone airports. These facilities enable users to host, recharge, and effectively deploy drones to their designated locations, further expanding the capabilities of unmanned aerial vehicles in diverse mission scenarios.

Vessi Medical

Venture Round in 2020
Vessi Medical is an Israeli medical device startup focused on innovating treatment for Non-Muscle-Invasive Bladder Cancer (NMIBC) through a novel surface cryotherapy approach. This technique employs extreme cold to freeze and eliminate abnormal tissue, providing a minimally invasive alternative to the standard TransUrethral Resection of Bladder Tumor (TURBT), which is often inadequate and requires invasive surgery under general anesthesia. Vessi's technology, comprising a standalone console and a disposable catheter, allows for targeted cell destruction while safeguarding healthy bladder tissue. This office-based procedure not only reduces the need for costly hospital stays and repeat surgeries but also addresses the high recurrence rate of NMIBC, which affects millions globally. With promising proof of concept already demonstrated in animal studies, Vessi aims to capture the $1.2 billion NMIBC market, while also exploring future applications for treating overactive bladder and urinary tract infections. The company is supported by experienced professionals in the medical device and cryotherapy sectors, ensuring a strong foundation for its innovations.

Soltell Systems

Grant in 2020
Soltell specializes in Industrial IoT-powered automation for the management of rooftop solar photovoltaic (PV) systems. The company's smart solar management platform allows for cost-effective supervision of distributed solar energy fleets, connecting solar service providers, commercial property owners, and smart city initiatives. Utilizing advanced process automation and proprietary sensorless weather measurement technology, Soltell enhances transparency and efficiency in the operation of rooftop solar PV installations. Its platform is designed to support a range of inverters and data loggers, making it compatible with both new and existing PV systems. By offering predictive maintenance capabilities, Soltell aids clients in optimizing the management and operation of decentralized solar energy systems, ultimately facilitating a transition to more resilient and efficient energy generation in urban settings.

RFISee

Series A in 2020
RFISee is focused on developing innovative radar technology aimed at enhancing the safety of autonomous vehicles. The company is creating the world's first 4D imaging radar on a single chip, which utilizes high-resolution, low-cost radar sensors to produce real-time 3D location and velocity maps of surrounding objects. This advanced technology is designed to support the automation of driving, paving the way for safer vehicles and enabling new transportation modes and business models. RFISee's radar systems are particularly beneficial due to their robustness, functioning effectively in various weather and light conditions, a characteristic that aligns with the needs of the rapidly growing autonomous car market.

Magentiq Eye

Non Equity Assistance in 2020
Magentiq Eye Ltd. is a medical device company based in Haifa, Israel, established in 2014. The company specializes in enhancing endoscopic procedures through advanced technologies such as artificial intelligence, deep learning, and computer vision. Its flagship product is the Automatic Polyp Detection System (APDS), which aids physicians during colonoscopy by automatically identifying suspicious polyp locations in real-time or in offline mode on pre-recorded videos. This innovation is designed to improve the accuracy of polyp detection, thereby reducing the miss-rate associated with colonoscopies, which can lead to interval cancer. Given the high volume of colonoscopy procedures performed annually, Magentiq Eye's solutions aim to enhance diagnostic effectiveness, ultimately contributing to better patient outcomes and significant healthcare cost savings. The APDS can be integrated with existing colonoscopy systems or offered as a service to clinics and hospitals, positioning Magentiq Eye as a key player in the medical device industry focused on improving endoscopic practices.

SafeUP - Women's Safety Net

Pre Seed Round in 2020
90 days from launch (Dec 20): - 4 paying clients in 90 days, 25 days sales cycle. - 10,000 users covering all 10 largest cities of Israel. Together with our SafeUPer we - Create a Safe World for Women - One community at a time. Create – We believe people must take an action, getting out of our comfort zone, to achieve this change. Sharing stories is simply not enough. Safe – We believe being safe is a basic right of all women, and like all women right achieved by previous generations, it will be gained with sweat and tears. World – We are facing a global problem, documented for at least two millennia (2,000 yrs), maybe the only problem impacting women daily, of all ages, countries, backgrounds and beliefs. Therefore. We believe it should be solved globally, empowering women all around the world to bring safety to their local communities. Women – We believe that when women will have peace, men too will have peace. Men have proven that they are unable to bring peace and safety by themselves to themselves nor to women. Therefore, we need to lead and bring it together.

Baseline Vision

Grant in 2020
Baseline Vision is a developer of a cloud-based game analytics platform tailored for the net-sports market, with a primary focus on tennis. The company offers a scalable solution that utilizes a single portable smart-camera device to deliver real-time game analysis. This innovative technology unlocks a range of digital products, including line-calling, performance tracking, on-court gamification, and video feedback. Through its platform, Baseline Vision enables tennis players and coaches to review past training sessions, monitor their progress, connect with other players, and share content on social media. The integration of these features enhances the training experience and fosters a community among users.

DiA Imaging Analysis

Grant in 2020
DiA Imaging Analysis Ltd. is a technology company based in Beersheba, Israel, specializing in AI-powered ultrasound analysis designed to enhance the evaluation of cardiac function and other medical conditions. Founded in 2009, DiA offers a range of innovative applications, including LVivo EF for automated ejection fraction evaluation, LVivo RV for right ventricle analysis, and LVivo Strain, which assesses myocardial strain as an early indicator of reduced left ventricular function. Their tools simplify the ultrasound imaging process by providing automated analysis and optimal view selection, improving the diagnostic capabilities of clinicians. DiA's technology is compatible with various ultrasound devices and healthcare IT systems, streamlining the detection of clinical abnormalities. The company holds FDA and CE clearances and serves thousands of users globally, addressing critical challenges in ultrasound utilization by enabling more accurate and efficient image analysis through advanced pattern recognition and machine learning algorithms.

XRHealth

Grant in 2020
XRHealth Ltd. is a medical technology company based in Tel Aviv, Israel, that specializes in developing virtual reality (VR) software solutions for healthcare. Founded in 2016, the company offers an array of products designed to enhance patient care and treatment outcomes. Its offerings include VRPhysio, a platform for virtual physical therapy; VRReliever, which helps manage pain through distraction; VRCogni, aimed at improving motor function in stroke and dementia patients; and VRPsyc, which provides exposure therapy for various mental health disorders. Additionally, VRCoordi is designed to aid coordination recovery in patients with Parkinson's, brain injuries, and autism. By integrating immersive technologies with licensed clinicians and advanced data analytics, XRHealth provides comprehensive telehealth services, allowing patients to access treatment from the comfort of their own homes.

Caaresys

Seed Round in 2020
Caaresys is a developer of advanced vehicle passenger monitoring systems aimed at preventing vehicle-related tragedies. The company's innovative technology utilizes a contactless low-emission radio frequency radar to monitor vehicle occupancy and vital signs, including heart rate and respiratory rate. This system is designed to activate warnings on a paired mobile device and trigger the car alarm when necessary, enabling users to detect potential dangers early and take appropriate precautions. Caaresys has established partnerships with leading suppliers and has secured licensing agreements for significant deployment within the automotive sector. The company is engaged in multiple projects across various domains, including automotive applications, aftermarket solutions such as child detection systems for school buses, and health monitoring initiatives, including vital signs monitoring in medical beds and COVID test stations. Its patented technology, developed by an in-house team of experts, positions Caaresys as a preferred vendor within the industry.

Cymptom

Grant in 2020
Cymptom is a cybersecurity company that offers a platform designed to protect organizations from cyber breaches by proactively assessing and visualizing potential attack paths. Utilizing agentless data collection technology, Cymptom maps critical risks to the MITRE ATT&CK® framework, enabling continuous monitoring of both on-premises and cloud environments. The platform identifies breach scenarios and pinpoints vulnerabilities without the need for attack simulations or interference with existing security measures. This approach allows organizations to receive real-time assessments of their security posture, prioritize mitigation strategies, and maintain operational continuity. By providing always-on cyber resilience, Cymptom supports business initiatives while minimizing the risk of cyber threats.

Enlivex Therapeutics

Grant in 2020
Enlivex Therapeutics Ltd. is a clinical-stage immunotherapy company headquartered in Nes Ziona, Israel, focused on developing allogeneic drugs aimed at rebalancing the immune system. The company's lead product, Allocetra, is an immunotherapy candidate currently undergoing multiple clinical trials. These include a Phase IIb trial for severe sepsis, an investigator-initiated Phase II trial for COVID-19 patients in severe and critical conditions, and a Phase IIa trial for preventing Graft Versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplants. Additionally, Enlivex is exploring Allocetra's potential in preventing complications from bone marrow transplants and acute multiple organ failure. The company also aims to develop cell-based therapies that enhance the efficacy of treatments for solid tumors through immune checkpoint rebalancing. Founded in 2005 by Professor Dror Mevorach, Enlivex utilizes a novel approach that focuses on inducing immune tolerance by employing apoptotic cells to modulate inflammatory and autoimmune responses.

Nobio

Grant in 2020
Nobio Ltd. is a biotechnology company based in Petah Tikva, Israel, specializing in the development of innovative nano-polymer additives that provide protection against microbial infections. Its technology enables the transformation of both implantable and non-implantable devices into biofilm-resistant platforms. Nobio's product offerings include a universal bonding agent designed for strong adhesion to various dental surfaces and restorative materials, as well as flowable composites suitable for dental restorations and sealants. The core of Nobio's technology consists of potent particles embedded with highly-active antimicrobial structures that kill bacteria upon contact, effectively preventing medical device contamination indefinitely. This unique approach positions Nobio as a leader in the creation of durable antimicrobial materials and surfaces, enhancing safety and efficacy in medical and dental applications.

AgroScout

Seed Round in 2020
AgroScout Ltd. is an Israeli company established in 2017 that specializes in developing an artificial intelligence-based platform aimed at enhancing sustainable farming practices. The company's technology provides precision agriculture solutions by utilizing advanced analytics and high-resolution aerial imagery to assess crop health and monitor for pests and diseases. AgroScout's platform supports farmers by offering insights on crop emergence, stand counts, canopy coverage, and biomass throughout the growing season. This continuous monitoring allows for early detection of infestations, enabling more effective curative treatments and reducing pesticide use. By delivering actionable insights into crop management and regional outbreak predictions, AgroScout aims to improve crop yields and profitability while fostering a more sustainable food production supply chain.

BrainStorm Cell Therapeutics

Grant in 2020
BrainStorm Cell Therapeutics Inc. is a biotechnology company focused on developing and commercializing adult stem cell therapies for neurodegenerative diseases. Their proprietary technology, NurOwn, utilizes a patient's own mesenchymal stem cells, which are engineered to produce neurotrophic factors that promote neuronal survival. The company is actively advancing NurOwn through clinical trials for conditions such as amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and Parkinson's disease. Currently, NurOwn is in a Phase III clinical trial for ALS and a Phase II trial for MS, with plans for preclinical studies targeting Parkinson’s disease, Huntington’s disease, and autism spectrum disorder. BrainStorm has partnered with Catalent for the manufacturing of NurOwn, ensuring the production of this autologous cellular therapy. Founded in 2000 and headquartered in New York, BrainStorm Cell Therapeutics was previously known as Golden Hand Resources Inc. before rebranding in 2004.

Aquafit Intimate

Seed Round in 2020
Aquafit Intimate is a pioneer in the field of intimate wellness. Our mission is to empower women to take control of their intimate wellness through self-care, for women of all ages. - An ask anything AI companion for personalised gynae wellness self assessments and getting help. - Our flagship Intimate Gel Stick family, which combines vaginal muscle training with the delivery of natural extracts to help restore elasticity, hydration, and pH balance for pain-free intimacy. Our products and services address very common intimate wellness conditions, central to women's health and wellbeing.

Indoor Robotics

Grant in 2020
Indoor Robotics Ltd, founded in 2018 and based in Ramat Gan, Israel, specializes in the design and development of Tando, an innovative AI-powered patrol drone tailored for indoor security and inspection tasks. The drone employs independent AI navigation and a patented unobtrusive ceiling docking system, providing real-time monitoring and predictive analysis to minimize false alarms. Tando's automated data collection and analysis capabilities ensure consistent quality, enhancing safety and security measures. By integrating robotics with advanced AI, Indoor Robotics aims to deliver efficient and cost-effective solutions for intelligent indoor monitoring. Collaborating with leaders in the security and smart building sectors, the company is at the forefront of transforming indoor surveillance and inspection through cutting-edge technology.

Brevel

Grant in 2020
Brevel is a company that specializes in innovative cultivation technology for microalgae, aimed at producing sustainable and high-quality products for various emerging markets. Utilizing advanced indoor systems that are sterile and fully automated, Brevel's method employs high-intensity internal illumination, resulting in significant cost reductions of over 90% and yield increases of up to 200 times compared to traditional methods. This breakthrough technology positions Brevel to capitalize on the growing demand for microalgae-derived products in sectors such as food, materials, chemicals, pharmaceuticals, and energy, providing an alternative protein source suitable for mass production.

TaTiO

Pre Seed Round in 2020
TaTiO is a company that specializes in enhancing the recruitment process through its innovative virtual job simulation application. By leveraging AI technology, TaTiO allows candidates to experience job roles in a simulated environment, fostering an emotional connection to the position. This approach not only screens candidates based on their actual skills but also matches them with suitable job opportunities. As a result, TaTiO helps businesses optimize their hiring processes by increasing application and engagement rates, thereby improving the quality of leads and significantly reducing candidate drop-off rates. Through its unique methodology, TaTiO aims to create a more effective and engaging recruitment experience for both employers and candidates.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.